Hello and Welcome to Patientsville.com, Your Source for all MAVIK information. We are dedicated to provide You with MAVIK safety information. Learn about MAVIK serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MAVIK Safety Reports
Total MAVIK reports: 42.MAVIK FDA safety alerts: No.
Reported deaths: 9 Reported hospitalizations: 17.
Take MAVIK Side Effects Survey or Share Your MAVIK Story. Read More Here.
Physician from CANADA reported MAVIK problem on Feb 14, 2007. Male patient, weighting 172.0 lb, was diagnosed with hypertension, gastrooesophageal reflux disease and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on Feb 21, 2007. Male patient, weighting 172.0 lb, was diagnosed with hypertension, gastrooesophageal reflux disease, mineral supplementation and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: diverticulum intestinal haemorrhagic. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Health Professional from CANADA reported MAVIK problem on Mar 27, 2007. Male patient, weighting 165.3 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: cervical vertebral fracture, head injury. MAVIK dosage: unknown. Patient died on 02/07/2007.
MAVIK problem was reported by a Physician from CANADA on Apr 16, 2007. Male patient, weighting 219.4 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm. MAVIK dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, METOPROLOL TARTRATE, AMLODIPINE BESYLATE, NITRO, CRESTOR, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from CANADA reported MAVIK problem on Apr 19, 2007. Female patient, 83 years of age, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: malaise, renal failure acute. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on May 03, 2007. Male patient, 57 years of age, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from CANADA reported MAVIK problem on May 08, 2007. Female patient, weighting 204.4 lb, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: arterial stenosis, retroperitoneal haematoma, ventricular tachycardia. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on May 15, 2007. Female patient, weighting 149.9 lb, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, orthostatic hypotension. MAVIK dosage: unknown. During the same period patient was treated with PROPRANOLOL. Patient recovered.
Physician from CANADA reported MAVIK problem on May 17, 2007. Male patient, 57 years of age, weighting 160.9 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on May 15, 2007. Female patient, weighting 136.7 lb, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: renal artery stenosis. MAVIK dosage: unknown. Patient recovered.
Physician from CANADA reported MAVIK problem on May 22, 2007. Male patient, 57 years of age, weighting 160.9 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Health Professional from AUSTRALIA on May 29, 2007. Male patient, weighting 194.0 lb, was diagnosed with cardiac failure congestive, gout and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, renal failure acute. MAVIK dosage: unknown. During the same period patient was treated with LUMIRACOXIB, CARVEDILOL, ALLOPURINOL, PREGABALIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Physician from CANADA reported MAVIK problem on May 29, 2007. Female patient, weighting 149.9 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: abdominal pain, aortic stenosis, eye pain, headache, orthostatic hypotension. MAVIK dosage: unknown. During the same period patient was treated with PROPRANOLOL. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on May 31, 2007. Female patient, weighting 136.7 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: blood creatinine abnormal, glomerular filtration rate decreased, renal artery stenosis. MAVIK dosage: unknown. Patient recovered.
Physician from CANADA reported MAVIK problem on June 01, 2007. Female patient, weighting 211.6 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: hip fracture, wrist fracture. MAVIK dosage: unknown. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on June 04, 2007. Female patient, weighting 132.3 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: radius fracture. MAVIK dosage: unknown. Patient recovered.
Physician from CANADA reported MAVIK problem on June 06, 2007. Female patient, weighting 197.2 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on June 06, 2007. Male patient, weighting 157.6 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. Patient died.
Consumer or non-health professional from UNITED STATES reported MAVIK problem on June 08, 2007. Female patient, 84 years of age, weighting 129.2 lb, was diagnosed with cardiac failure congestive and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, gastric cancer, hypotension, mineral deficiency, oedema peripheral. MAVIK dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, METOPROLOL TARTRATE, METOPROLOL TARTRATE, FUROSEMIDE, CARVEDILOL, ENALAPRIL MALEATE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on June 13, 2007. Male patient, weighting 158.7 lb, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis, lung neoplasm malignant. MAVIK dosage: unknown. Patient recovered.
Physician from CANADA reported MAVIK problem on June 19, 2007. Female patient, weighting 132.3 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: bone disorder, radius fracture. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, AMLODIPINE. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on June 21, 2007. Female patient, weighting 168.2 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: breast cancer. MAVIK dosage: unknown. During the same period patient was treated with GLICLAZIDE. Patient recovered.
Physician from CANADA reported MAVIK problem on June 21, 2007. Male patient, weighting 158.7 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, metastases to central nervous system. MAVIK dosage: unknown. During the same period patient was treated with CELECOXIB. Patient recovered.
MAVIK problem was reported by a Health Professional from CANADA on June 22, 2007. Female patient, weighting 132.3 lb, was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. MAVIK dosage: unknown. During the same period patient was treated with FUROSEMIDE. Patient died on 12/07/2006.
Consumer or non-health professional from UNITED STATES reported MAVIK problem on Aug 30, 2006. Male patient, weighting 190.2 lb, was diagnosed with blood pressure and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, syncope. MAVIK dosage: unknown. During the same period patient was treated with VERAPAMIL, ACETYLSALICYLIC ACID, FISH OIL, VITAMIN. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on Oct 17, 2006. Female patient, weighting 113.1 lb, was diagnosed with hypertension, osteoarthritis and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient died on 09/13/2006.
Physician from CANADA reported MAVIK problem on Nov 17, 2006. Female patient, 70 years of age, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. MAVIK dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, LEVOTHYROXINE, ESOMEPRAZOLE MAGNESIUM, OXAZEPAM. Patient was hospitalized. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on Nov 27, 2006. Male patient, 81 years of age, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MAVIK dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from CANADA reported MAVIK problem on Dec 07, 2006. Male patient, weighting 180.2 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: prostate cancer. MAVIK dosage: unknown. Patient recovered.
MAVIK problem was reported by a Physician from UNITED STATES on Dec 12, 2006. Female patient, weighting 121.1 lb, was diagnosed with multiple sclerosis and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: aggression, amnesia, aphasia, blood glucose decreased, depressed level of consciousness, disorientation, drooling, feeling abnormal, headache. MAVIK dosage: unknown. During the same period patient was treated with INTERFERON BETA, INSULIN, NORTRIPTYLINE. Patient was hospitalized. Patient recovered.
Health Professional from CANADA reported MAVIK problem on Dec 15, 2006. Male patient, weighting 173.3 lb, was diagnosed with hypertension, diabetes mellitus non-insulin-dependent, thrombosis prophylaxis, angina pectoris, hyperlipidaemia, arteriosclerosis coronary artery, mineral supplementation and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: circulatory collapse. MAVIK dosage: unknown. During the same period patient was treated with DIOVAN, MIXTARD, ASPIRIN, NITRO, CRESTOR, METOPROLOL SUCCINATE, FUROSEMIDE, MICRO. Patient died on 12/14/2006.
MAVIK problem was reported by a Physician from CANADA on Nov 27, 2006. Male patient, weighting 181.2 lb, was diagnosed with hypertension, anxiety, osteoarthritis and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: electrocardiogram st segment elevation, haematoma, myocardial infarction. MAVIK dosage: unknown. During the same period patient was treated with OXAZEPAM, CELECOXIB. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from CANADA reported MAVIK problem on June 27, 2007. Male patient, weighting 187.4 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: lung cancer metastatic. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.
MAVIK problem was reported by a Consumer or non-health professional from CANADA on June 27, 2007. Male patient, weighting 187.4 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: lung cancer metastatic. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.
Consumer or non-health professional from CANADA reported MAVIK problem on July 03, 2007. Male patient, weighting 160.3 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis. MAVIK dosage: unknown. During the same period patient was treated with ACEBUTOLOL. Patient died.
MAVIK problem was reported by a Consumer or non-health professional from FRANCE on July 12, 2007. Male patient, weighting 187.4 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: lung cancer metastatic. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.
Physician from CANADA reported MAVIK problem on July 13, 2007. Male patient, weighting 160.3 lb, was diagnosed with blood pressure inadequately controlled, hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, pneumonia, sepsis. MAVIK dosage: unknown. During the same period patient was treated with ACEBUTOLOL. Patient died.
MAVIK problem was reported by a Consumer or non-health professional from CANADA on Aug 09, 2007. Male patient, weighting 242.9 lb, was diagnosed with hypertension, hypercholesterolaemia, diabetes mellitus, cardiovascular event prophylaxis and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: prostate cancer. MAVIK dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, METFORMIN, ASPIRIN, HYDROCHLOROTHIAZIDE. Patient recovered.
Consumer or non-health professional from FRANCE reported MAVIK problem on Aug 15, 2007. Male patient, weighting 187.4 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: non-small cell lung cancer metastatic. MAVIK dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE. Patient recovered.
MAVIK problem was reported by a Physician from CANADA on Aug 23, 2007. Male patient, weighting 157.6 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, lung disorder, postinfarction angina. MAVIK dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, NIFEDIPINE, ROSUVASTATIN, ASPIRIN, ISOSORBIDE MONONITRATE, FERROUS SULPHATE, CALCIUM WITH VITAMIN D, RISEDRONATE. Patient died on 05/16/2007.
Consumer or non-health professional from CANADA reported MAVIK problem on Sept 05, 2007. Female patient, weighting 180.2 lb, was diagnosed with hypertension and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: dyspepsia, oesophageal carcinoma. MAVIK dosage: unknown. Patient died on 08/03/2007.
MAVIK problem was reported by a Consumer or non-health professional from CANADA on Sept 18, 2007. Male patient, weighting 169.2 lb, was diagnosed with hypertension, lipids increased, arteriosclerosis coronary artery, diabetes mellitus and was treated with MAVIK. After drug was administered, patient experienced the following problems/side effects: fall, hip fracture. MAVIK dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, AMLODIPINE, LOPRESSOR, GLICLAZIDE. Patient was hospitalized. Patient recovered.